Ivy Foundation Renews Support for TGen Neurological Sciences Internship Program. Second year of training opportunities focused on brain tumors and neuroscience
PHOENIX, Ariz. – May 8, 2013 – The Arizona-based Ben & Catherine Ivy Foundation will fund a second year of the Ivy Neurological Science Internship Program at the Translational Genomics Research Institute (TGen).
The internship program offers hands-on biomedical research experience for high school, undergraduate and aspiring medical school students pursuing careers in brain tumor research, neuroscience and neurogenomics.
Through the program, world-class scientific investigators at TGen guide interns in the translational process of moving laboratory discoveries along the pipeline into new treatments for patients in clinical trials.
“Based upon the success of the 2012 pilot year, we believe the Ivy Neurological Science Internship Program at TGen will inspire a new generation of leaders in this field,” said Catherine Ivy, President of The Ben & Catherine Ivy Foundation. “There is an urgent and continuing need to encourage research into the intricate workings of brain cancer.”
TGen will select seven students for the program this year. Starting in June, two high-school students will participate in a 10-week summer program. Four undergraduate students will spend the fall semester at TGen, and one student planning to attend medical school will participate for a full academic year, beginning in the fall.
“Development of a local, knowledge-based workforce depends on educating and training talented students in the latest aspects of biomedical research and medicine,” said TGen President Dr. Jeffrey Trent. “The continued support from the Ivy program greatly enhances our efforts to provide hands-on experience in the area of translational research.”
In addition to brain tumor and neurological sciences research experience, Ivy interns will participate in a clinical training module that will engage them with the ultimate focus of these studies – the patient.
“TGen recognizes that we must invest in the development of the next generation of researchers and physicians; we need to prepare today’s students for the complex and challenging work awaiting them in the areas of brain tumor and neurological sciences research,” said Brandy Wells, Manager of TGen’s Education and Outreach.
For more information, please contact Brandy Wells at email@example.com or 602-343-8655.
# # #
About The Ben & Catherine Ivy Foundation
The Ben & Catherine Ivy Foundation, based in Scottsdale, Ariz., was formed in 2005, when Ben Ivy lost his battle with glioblastoma multiforme (GBM). Since then, the Foundation has contributed more than $50 million to research in gliomas within the United States and Canada, with the goal of better diagnostics and treatments that offer long-term survival and a high quality of life for patients with brain tumors. The Ben & Catherine Ivy Foundation is the largest privately funded foundation of its kind in the United States. For more information, visit www.ivyfoundation.org. Connect with The Ben & Catherine Ivy Foundation on Facebook at www.facebook.com/IvyFoundation and on Twitter @IvyFoundation.
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.
TGen Senior Science Writer